Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use RIASTAP® safely and effectively. See full prescribing information for RIASTAP. RIASTAP, Fibrinogen Concentrate (Human)Lyophilized Powder for Solution for Intravenous InjectionInitial U.S. Approval: 2009
Medication labelWhy this: Advisory · dailymed-other
RIASTAP®, Fibrinogen Concentrate (Human) is a human blood coagulation factor indicated for the treatment of acute bleeding episodes in pediatric and adult patients with congenital fibrinogen deficiency, including afibrinogenemia and hypofibrinogenemia. Limitation of Use RIASTAP is not indicated for dysfibrinogenemia.
- generic_name
- fibrinogen human
- product_names
- FIBRINOGEN HUMAN
- ndc
- 63833-891, 63833-892, 63833-891-90, 63833-891-51, 63833-892-90, 63833-892-51
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en